Back to top

Lisata Therapeutics terminates merger with Kuva Labs

In a regulatory filing on Friday, Lisata Therapeutics (LSTA) disclosed that on July 24, the company terminated the previously announced agreement a...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Lisata Therapeutics, Inc. (LSTA)